Readily is one of the top 46 companies that are in the semi-final of the Founder-pitch competition at Techarena 2025! On Thursday 20th of February we will pitch at the Founder stage at Strawberry arena in Stockholm.

Readily Diagnostics strengthens its team with the recruitment of Jon Wallgren as Senior Production Engineer. Jon is an experienced process engineer and brings extensive experience from production processes in medical device and the IVD industry, with expertise in working in regulated environment, most recently from a position at Sysmex Astrego. This strategic recruitment enhances our ability to deliver high-quality infectious disease diagnostic products to the market.

Readily´s CEO and Co-founder Liza Löf is awarded 2024 SKAPA price - Uppsala section

Readily Diagnostics strengthens its management team with the appointment of Anna-Karin Roberto as Director of Quality & Regulatory Affairs.

Readily Diagnostics, is pleased to announce the successful closure of a €1.6 M capital round. The capital round was led by founders and existing shareholders, now joined by new investors, including the Beijer Foundation and LF Uppsala.

We are pleased to announce that we have been granted funding from the Bio-X Accelerate Program. This support will enable us to advance the development and market introduction of our next-generation rapid diagnostic tests for respiratory diseases, enhancing patient care by providing faster and more accurate diagnostics.

Meet us at The Global Laboratory Medicine Community McCormick Place Convention Center Chicago, IL, USA

Come and meet us at UID at Studenternas the 26th of September 2024

Readily presented at Uppsala Innovation Day - UID and was awarded price of highest investment.

10 June 2023

We received fundig from Vinnova´s innovation program Metdtech4Health. This will aid us in our development of rapid diagnostics for inectious disease